Article
FTC And DOJ Secure $12 Million Settlement For HSR Act Violations In Edwards/JC Medical Deal
The FTC and DOJ secured a landmark $12 million settlement against Edwards Lifesciences and Genesis MedTech for allegedly structuring a medical device acquisition to circumvent Hart-Scott-Rodino Act filing requirements. This enforcement action, coupled with the agencies' successful challenge to Edwards' subsequent JenaValve acquisition, signals heightened scrutiny of pre-commercial pipeline deals and aggressive enforcement of merger notification obligations in the healthcare sector.
Arnold & Porter